MoneyWorks4Me

ICRA upgrades Indoco Remedies’ long term rating to ‘AA-’

23 Jul 2021 Evaluate

Credit rating agency -- ICRA has upgraded Indoco Remedies’ long term rating to ‘AA-’ from ‘A+’. The outlook on the long-term rating is stable. The short term rating of company has been revised to ‘A1+’ from ‘A1’.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..